ANNA logo
Continuing Nursing Education

.

Assessment of the Impact of Weekly Versus Monthly Erythropoiesis Stimulating Protein Therapy on Patients with CKD and Their Families - Download article and take CE posttest
Denise Globe, Deborah Glidden, Joachim Hertel, Joele Thomas, Michele Ackerman, Felicia Chidolue, Bianca Blanco, Annette Borden, Thomas F. Goss, Xiao Xu, and Reshma Kewalramani

This cross-sectional study measured patient and family member reported treatment and economic burden associated with monthly versus weekly erythropoiesis stimulating protein therapies for anemia in patients with CKD who were not yet on dialysis. The results indicated that compared to a weekly regimen, a monthly regimen saved patients 7 hours and family members 19 hours per month for routine anemia management. The monthly regimen substantially reduced the reported economic and treatment burdens of patient and their family members.


Denise Globe, PhD, is Director, Global Health Economics & Outcomes Research, Amgen Inc., Thousand Oaks, CA. She has disclosed that she is a major stock holder of Amgen, Inc.
Deborah Glidden, MSN, ARNP-C, CNN, is Nurse Practitioner, CKD Clinic & Research, Nephrology Associates of Central Florida, PA, Orlando, FL. She is a member of ANNA’s Sunshine Central Chapter.
Joachim Hertel, MD, FACP, is Staff Physician, Nephrology Associates, PC, Augusta, GA. He has disclosed that he received grant/research support from Amgen, Inc. and is a on the consultant presenter bureau of Amgen, Inc.
Joele Thomas, BSN, RN, is Study Coordinator, Western New England Renal and Transplant Associates, Springfield, MA.
Michele Ackerman, ASN, RN, is Nurse Manager, Nephrology Associates of Central Florida, PA, Orlando, FL.
Felicia Chidolue, MSN, RN, FNP-C, is Sub-Investigator, Study Coordinator, Southwest Houston Research, Houston, TX.
Bianca Blanco, BSN, RN, is Clinical Research Coordinator, Clinical Research Associates, LLC, Palm Beach Gardens, FL.
Annette Borden, MA, is Lead Medical Assistant, Western Washington Medical Group – Nephrology, Everett, WA.
Thomas F. Goss, PharmD, is Vice President, Consulting Services, Covance Market Access Services, Inc., Gaithersburg, MD. He disclosed that research funding was provided to Covance Inc. by Amgen, Inc.
Xiao Xu, PhD, RN, is Principal, Consulting Services, Covance Market Access Services, Inc., Gaithersburg, MD. She disclosed that research funding was provided to Covance Inc. by Amgen, Inc.
Reshma Kewalramani, MD, is Director, Medical Affairs – Nephrology, Amgen Inc., Thousand Oaks, CA. She has disclosed that she is a major stock holder of Amgen, Inc.